Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 16
2003 20
2004 29
2005 23
2006 28
2007 21
2008 16
2009 22
2010 42
2011 38
2012 41
2013 42
2014 39
2015 25
2016 39
2017 42
2018 50
2019 58
2020 24
Text availability
Article attribute
Article type
Publication date

Search Results

536 results
Results by year
Filters applied: . Clear all
Page 1
Gut microbiota in the pathogenesis of inflammatory bowel disease.
Nishida A, Inoue R, Inatomi O, Bamba S, Naito Y, Andoh A. Nishida A, et al. Among authors: naito y. Clin J Gastroenterol. 2018 Feb;11(1):1-10. doi: 10.1007/s12328-017-0813-5. Epub 2017 Dec 29. Clin J Gastroenterol. 2018. PMID: 29285689 Review.
A next-generation beneficial microbe: Akkermansia muciniphila.
Naito Y, Uchiyama K, Takagi T. Naito Y, et al. J Clin Biochem Nutr. 2018 Jul;63(1):33-35. doi: 10.3164/jcbn.18-57. Epub 2018 Jun 20. J Clin Biochem Nutr. 2018. PMID: 30087541 Free PMC article. Review.
Heme oxygenase-1 and anti-inflammatory M2 macrophages.
Naito Y, Takagi T, Higashimura Y. Naito Y, et al. Arch Biochem Biophys. 2014 Dec 15;564:83-8. doi: 10.1016/j.abb.2014.09.005. Epub 2014 Sep 18. Arch Biochem Biophys. 2014. PMID: 25241054 Review.
Intestinal microbiome as a novel therapeutic target for local and systemic inflammation.
Uchiyama K, Naito Y, Takagi T. Uchiyama K, et al. Among authors: naito y. Pharmacol Ther. 2019 Jul;199:164-172. doi: 10.1016/j.pharmthera.2019.03.006. Epub 2019 Mar 12. Pharmacol Ther. 2019. PMID: 30877020 Review.
Clinical and Pharmacokinetic Factors Associated With Adalimumab-Induced Mucosal Healing in Patients With Crohn's Disease.
Watanabe K, Matsumoto T, Hisamatsu T, Nakase H, Motoya S, Yoshimura N, Ishida T, Kato S, Nakagawa T, Esaki M, Nagahori M, Matsui T, Naito Y, Kanai T, Suzuki Y, Nojima M, Watanabe M, Hibi T; DIAMOND study group. Watanabe K, et al. Among authors: naito y. Clin Gastroenterol Hepatol. 2018 Apr;16(4):542-549.e1. doi: 10.1016/j.cgh.2017.10.036. Epub 2017 Nov 11. Clin Gastroenterol Hepatol. 2018. PMID: 29104132 Free article. Clinical Trial.
Adalimumab Monotherapy and a Combination with Azathioprine for Crohn's Disease: A Prospective, Randomized Trial.
Matsumoto T, Motoya S, Watanabe K, Hisamatsu T, Nakase H, Yoshimura N, Ishida T, Kato S, Nakagawa T, Esaki M, Nagahori M, Matsui T, Naito Y, Kanai T, Suzuki Y, Nojima M, Watanabe M, Hibi T; DIAMOND study group. Matsumoto T, et al. Among authors: naito y. J Crohns Colitis. 2016 Nov;10(11):1259-1266. doi: 10.1093/ecco-jcc/jjw152. Epub 2016 Aug 26. J Crohns Colitis. 2016. PMID: 27566367 Clinical Trial.
The JAK/STAT pathway is involved in the upregulation of PD-L1 expression in pancreatic cancer cell lines.
Doi T, Ishikawa T, Okayama T, Oka K, Mizushima K, Yasuda T, Sakamoto N, Katada K, Kamada K, Uchiyama K, Handa O, Takagi T, Naito Y, Itoh Y. Doi T, et al. Among authors: naito y. Oncol Rep. 2017 Mar;37(3):1545-1554. doi: 10.3892/or.2017.5399. Epub 2017 Jan 23. Oncol Rep. 2017. PMID: 28112370
Intestinal Dysbiosis Secondary to Proton-Pump Inhibitor Use.
Naito Y, Kashiwagi K, Takagi T, Andoh A, Inoue R. Naito Y, et al. Digestion. 2018;97(2):195-204. doi: 10.1159/000481813. Epub 2018 Jan 6. Digestion. 2018. PMID: 29316555 Review.
Similar Efficacy of Proton-Pump Inhibitors vs H2-Receptor Antagonists in Reducing Risk of Upper Gastrointestinal Bleeding or Ulcers in High-Risk Users of Low-Dose Aspirin.
Chan FK, Kyaw M, Tanigawa T, Higuchi K, Fujimoto K, Cheong PK, Lee V, Kinoshita Y, Naito Y, Watanabe T, Ching JY, Lam K, Lo A, Chan H, Lui R, Tang RS, Sakata Y, Tse YK, Takeuchi T, Handa O, Nebiki H, Wu JC, Abe T, Mishiro T, Ng SC, Arakawa T. Chan FK, et al. Among authors: naito y. Gastroenterology. 2017 Jan;152(1):105-110.e1. doi: 10.1053/j.gastro.2016.09.006. Epub 2016 Sep 15. Gastroenterology. 2017. PMID: 27641510 Clinical Trial.
Phase I clinical trial of adoptive transfer of expanded natural killer cells in combination with IgG1 antibody in patients with gastric or colorectal cancer.
Ishikawa T, Okayama T, Sakamoto N, Ideno M, Oka K, Enoki T, Mineno J, Yoshida N, Katada K, Kamada K, Uchiyama K, Handa O, Takagi T, Konishi H, Kokura S, Uno K, Naito Y, Itoh Y. Ishikawa T, et al. Among authors: naito y. Int J Cancer. 2018 Jun 15;142(12):2599-2609. doi: 10.1002/ijc.31285. Epub 2018 Feb 14. Int J Cancer. 2018. PMID: 29388200 Free article. Clinical Trial.
536 results
Jump to page
Feedback